absolute money pit - I think I worked out it costs like 500k per patient in ph3 trial. How does this compare to other similar trials? Seems like a exceptionally high amount for a layman like me
- Forums
- ASX - By Stock
- OPT
- Ann: Opthea announces A$80m Capital raise
Ann: Opthea announces A$80m Capital raise, page-27
-
- There are more pages in this discussion • 47 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OPT (ASX) to my watchlist
(20min delay)
|
|||||
Last
61.8¢ |
Change
0.008(1.23%) |
Mkt cap ! $750.9M |
Open | High | Low | Value | Volume |
61.0¢ | 62.0¢ | 59.0¢ | $560.5K | 925.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
34 | 36575 | 61.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
62.0¢ | 66642 | 27 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
34 | 36575 | 0.615 |
17 | 13346 | 0.610 |
9 | 27371 | 0.605 |
10 | 43880 | 0.600 |
8 | 84543 | 0.595 |
Price($) | Vol. | No. |
---|---|---|
0.620 | 67883 | 26 |
0.625 | 82438 | 18 |
0.630 | 137354 | 12 |
0.635 | 194114 | 5 |
0.640 | 27595 | 7 |
Last trade - 14.51pm 13/09/2024 (20 minute delay) ? |
Featured News
OPT (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online